Truist Financial raised its target price and gave a 'buy' rating for CVS Health.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised its target price and gave a 'buy' rating for CVS Health.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CVS Health
company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
Related events
- Financial firms including Truist, RBC, TD Cowen, and Jefferies issued various rating updates on October 30, 2026.
- RBC raised price targets, Citigroup reaffirmed buy ratings, and Truist Financial upgraded VSE shares, with MarketBeat and Benzinga reporting the financial data.
- Leerink Partners decreased its target price on CVS Health, while BNP Paribas and Wyoming increased their holdings.
- Financial firms including Bank of America, Morgan Stanley, and Truist Financial adjusted price targets and ratings for Somnigroup International Inc.
- Bank of America, Truist Financial, and Raymond James Financial issued rating updates and price targets for Teleflex.